Herbridge, 30 May 2011_The overall silymarin market basically remained stable in the past two months. The slight price fluctions primarily come from suppliers' competing for costomers.
The emerging company Panjin Heyun Group Senrong Pharmaceutical Co., Ltd told herbridge.com that the supply was 20 percents less than the demand. Despite the seeds continous arrival in the market, the demand still exceeds the supply. According to herbridge.com, there are 15 producers gaining drug approval number in China with two producers in Panjin. Panjin Heyun Group Senrong Pharmaceutical is one of the two producers. The company set its goal to produce 100 tons of silymarin serial products in 2011. Although the planting area increases in 2011, it is still hard to predict the future market which has serveral affecting factors.
The market basically stable now. The two normal products with aceton extraction, UV80 + 30% silybin and UV80 +30% silybin & isosilybin, are respectively quoted around 550RMB/kg and 500 RMB/kg.
Copyright: www.herbridge.com
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
